IP Library Granted Patent US 12,059,439
Granted Patent B2
US 12,059,439 · App. 17/149,465 · Granted Aug 13, 2024

Osteoinductive putties and methods of making and using such putties

Inventor: Jordan Katz (Short Hills, NJ)
Assignee: RTI Surgical, Inc.
A61K35/32A61L27/24A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,059,439
App. No.
17/149,465
Granted
Aug 13, 2024
Kind
B2
Abstract

The present disclosure relates to osteoinductive putties and other implantable compositions for repair of bone defects and other medical uses. Specifically, the technology pertains to carriers for use in implantable compositions, such as osteoinductive putties. The osteoinductive putties are made entirely from donor tissue such as demineralized bone matrix, and the putties have excellent physical properties. The present disclosure relates to osteoinductive putties, carriers, compositions, implants, kits, methods of making and methods of using any of the foregoing.

Claims (45)

1. An osteoinductive putty comprising at least three components, wherein said components comprise:

i. demineralized bone matrix,

ii. a carrier comprising a mixture of thermally denatured collagen fragments, and

iii. a further component, wherein said further component comprises one or more osteogenic substances, osteoinductive substances, osteoconductive substances and/or medically useful substances;

wherein said thermally denatured collagen fragments comprising said carrier are derived from thermal treatment of demineralized bone matrix; and

wherein said mixture of thermally denatured collagen fragments has a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) profile, and said SDS-PAGE profile comprises a region between about 29 kDa and about 97 kDa, wherein said region is without prominent, intense, or discernable bands as compared to a Type-I collagen reference material.

2. The osteoinductive putty of claim 1 , wherein said mixture of thermally denatured collagen fragments has a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) profile substantially the same as shown in Lane C of any of FIG. 2 A, 2 B, 2 C , or 2 D.

3. The osteoinductive putty of claim 1 , wherein said thermally denatured collagen fragments are formed from heating said demineralized bone matrix at about 120° C. for about 90 min.

4. The osteoinductive putty of claim 1 , wherein the putty is adapted for packing into a bone defect.

5. The osteoinductive putty of claim 1 , wherein said further component comprises one or more osteogenic substances.

6. The osteoinductive putty of claim 5 , wherein said osteogenic substances comprise osteoblasts, stem cells and/or multipotent adult progenitor cells.

7. The osteoinductive putty of claim 1 , wherein said further component comprises one or more osteoinductive substances.

8. The osteoinductive putty of claim 7 , wherein said osteoinductive substances comprise osteoinductive proteins from the transforming growth factor-beta (TGF-beta) superfamily of proteins.

9. The osteoinductive putty of claim 7 , wherein said wherein said osteoinductive substances comprise bone morphogenetic proteins (BMPs), other naturally produced or recombinant growth factors and proteins, and/or fragments thereof.

10. The osteoinductive putty of claim 9 , wherein said bone morphogenetic proteins comprise BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7, BMP-9 (GDF-2),

BMP-10, BMP-12, BMP-13, BMP-15, BMP-16, BMP-17, and/or BMP-18.

11. The osteoinductive putty of claim 1 , wherein said further component comprises one or more osteoconductive substances.

12. The osteoinductive putty of claim 11 , wherein said osteoconductive substances comprise allograft bone, xenograft bone, calcium phosphate and/or hydroxyapatite.

13. The osteoinductive putty of claim 12 , wherein said allograft or xenograft bone comprises cortical cancellous chips.

14. The osteoinductive putty of claim 1 , wherein said further component comprises one or more medically useful substances.

15. The osteoinductive putty of claim 14 , wherein said medically useful substances comprise salts, antiviricides, antibiotics, anti-inflammatories or free radical scavengers.

16. An osteoinductive putty comprising at least three components, wherein said components comprise:

i. demineralized bone matrix,

ii. a carrier comprising a mixture of thermally denatured collagen fragments, and wherein said carrier is made by the process comprising:

a) providing a collagen source comprising collagen;

b) combining the collagen source with a denaturing solution other than water or saline to create a collagen source mixture;

c) heating the collagen source mixture to a temperature greater than 100° C.; and

d) maintaining said temperature for about 90 minutes; and

iii. a further component, wherein said further component comprises one or more osteogenic substances, osteoinductive substances, osteoconductive substances and/or medically useful substances;

wherein said thermally denatured collagen fragments comprising said carrier are derived from thermal treatment of demineralized bone matrix.

17. The osteoinductive putty of claim 16 , wherein said thermally denatured collagen fragments are formed from heating said demineralized bone matrix at about 120° C. for about 90 min.

18. The osteoinductive putty of claim 16 , wherein the putty is adapted for packing into a bone defect.

19. The osteoinductive putty of claim 16 , wherein the putty remains extrudable after extended storage in a sealed package.

20. The osteoinductive putty of claim 16 , wherein said further component comprises one or more osteogenic substances.

21. The osteoinductive putty of claim 20 , wherein said osteogenic substances comprise osteoblasts, stem cells and/or multipotent adult progenitor cells.

22. The osteoinductive putty of claim 16 , wherein said further component comprises one or more osteoinductive substances.

23. The osteoinductive putty of claim 22 , wherein said osteoinductive substances comprise osteoinductive proteins from the transforming growth factor-beta (TGF-beta) superfamily of proteins.

24. The osteoinductive putty of claim 22 , wherein said wherein said osteoinductive substances comprise bone morphogenetic proteins (BMPs), other naturally produced or recombinant growth factors and proteins, and/or fragments thereof.

25. The osteoinductive putty of claim 24 , wherein said bone morphogenetic proteins comprise BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7, BMP-9 (GDF-2),

BMP-10, BMP-12, BMP-13, BMP-15, BMP-16, BMP-17, and/or BMP-18.

26. The osteoinductive putty of claim 16 , wherein said further component comprises one or more osteoconductive substances.

27. The osteoinductive putty of claim 26 , wherein said osteoconductive substances comprise allograft bone, xenograft bone, calcium phosphate and/or hydroxyapatite.

28. The osteoinductive putty of claim 27 , wherein said allograft or xenograft bone comprises cortical cancellous chips.

29. The osteoinductive putty of claim 16 , wherein said further component comprises one or more medically useful substances.

30. The osteoinductive putty of claim 29 , wherein said medically useful substances comprise salts, antiviricides, antibiotics, anti-inflammatories or free radical scavengers.

Assignments (6)
SECURITY INTEREST Recorded Sep 25, 2025
From: RTI SURGICAL, INC.; COOK BIOTECH INCORPORATED; TISSX, LLC
To: GOLUB CAPITAL MARKETS LLC, AS COLLATERAL AGENT
Reel/Frame 072924/0721 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2023
From: KATZ, JORDAN MICHAEL
To: REGENERATION TECHNOLOGIES, INC.
Reel/Frame 065528/0960 →
MERGER Recorded Nov 10, 2023
From: REGENERATION TECHNOLOGIES, INC.
To: REGENERATION TECHNOLOGIES, INC.
Reel/Frame 065529/0013 →
MERGER Recorded Nov 10, 2023
From: RTI BIOLOGICS, INC.
To: RTI SURGICAL, INC.
Reel/Frame 065536/0674 →
MERGER Recorded Nov 10, 2023
From: REGENERATION TECHNOLOGIES, INC.
To: RTI BIOLOGICS, INC.
Reel/Frame 065548/0178 →
CHANGE OF NAME Recorded Nov 10, 2023
From: REGENERATION TECHNOLOGIES, INC.
To: RTI BIOLOGICS
Reel/Frame 065548/0185 →
Continuity (4)
Continuation 15617234 · Jun 8, 2017
Continuation 12341917 · Dec 22, 2008
Provisional Application 61008887 · Dec 21, 2007
Related Publication 20210137993A1 · May 13, 2021